Adoption of Bevacizumab Biosimilars in Medicare Part B: Socioeconomic and Geographic Variation, 2019–2023

JCO Oncology Practice · Published 2026-07-07 · DOI 10.1200/op-26-00259

Authors (6)

Taemin Kim, Michael Sheen, Andrew Yang, Daniel Ryan, Alan Mach, Chien-Hsiang Weng

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Kim, T., Sheen, M., Yang, A., et al. (2026). Adoption of Bevacizumab Biosimilars in Medicare Part B: Socioeconomic and Geographic Variation, 2019–2023. JCO Oncology Practice. https://doi.org/10.1200/op-26-00259

Related articles